148 related articles for article (PubMed ID: 20334898)
1. Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma.
Hsueh C; Chang YS; Tseng NM; Liao CT; Hsueh S; Chang JH; Wu IC; Chang KP
Hum Pathol; 2010 Jul; 41(7):944-50. PubMed ID: 20334898
[TBL] [Abstract][Full Text] [Related]
2. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas.
Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
Hum Pathol; 2007 Apr; 38(4):564-9. PubMed ID: 17306334
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
4. Claudin upregulation in ovarian carcinoma effusions is associated with poor survival.
Kleinberg L; Holth A; Trope CG; Reich R; Davidson B
Hum Pathol; 2008 May; 39(5):747-57. PubMed ID: 18439941
[TBL] [Abstract][Full Text] [Related]
5. New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression.
Roychowdhury DF; Tseng A; Fu KK; Weinburg V; Weidner N
Cancer; 1996 Apr; 77(8):1419-26. PubMed ID: 8608524
[TBL] [Abstract][Full Text] [Related]
6. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
[TBL] [Abstract][Full Text] [Related]
7. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation.
Resnick MB; Gavilanez M; Newton E; Konkin T; Bhattacharya B; Britt DE; Sabo E; Moss SF
Hum Pathol; 2005 Aug; 36(8):886-92. PubMed ID: 16112005
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis.
Chua DT; Sham JS; Kwong DL; Choy DT; Au GK; Wu PM
Cancer; 1996 Jul; 78(2):202-10. PubMed ID: 8673993
[TBL] [Abstract][Full Text] [Related]
9. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
Fritzsche FR; Oelrich B; Johannsen M; Kristiansen I; Moch H; Jung K; Kristiansen G
Clin Cancer Res; 2008 Nov; 14(21):7035-42. PubMed ID: 18981000
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prognostic significance of tumor-associated tissue eosinophilia in nasopharyngeal carcinoma.
Leighton SE; Teo JG; Leung SF; Cheung AY; Lee JC; van Hasselt CA
Cancer; 1996 Feb; 77(3):436-40. PubMed ID: 8630949
[TBL] [Abstract][Full Text] [Related]
11. Expression of occludin and claudins 1, 3, 4, and 7 in urothelial carcinoma of the upper urinary tract.
Nakanishi K; Ogata S; Hiroi S; Tominaga S; Aida S; Kawai T
Am J Clin Pathol; 2008 Jul; 130(1):43-9. PubMed ID: 18550469
[TBL] [Abstract][Full Text] [Related]
12. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
[TBL] [Abstract][Full Text] [Related]
13. Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
Sobel G; Németh J; Kiss A; Lotz G; Szabó I; Udvarhelyi N; Schaff Z; Páska C
Gynecol Oncol; 2006 Nov; 103(2):591-8. PubMed ID: 16797678
[TBL] [Abstract][Full Text] [Related]
14. Claudins 1, 3, 4, 5 and 7 in esophageal cancer: loss of claudin 3 and 4 expression is associated with metastatic behavior.
Takala H; Saarnio J; Wiik H; Soini Y
APMIS; 2007 Jul; 115(7):838-47. PubMed ID: 17614851
[TBL] [Abstract][Full Text] [Related]
15. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
16. Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue.
Bello IO; Vilen ST; Niinimaa A; Kantola S; Soini Y; Salo T
Hum Pathol; 2008 Aug; 39(8):1212-20. PubMed ID: 18547615
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
Denkert C; Winzer KJ; Müller BM; Weichert W; Pest S; Köbel M; Kristiansen G; Reles A; Siegert A; Guski H; Hauptmann S
Cancer; 2003 Jun; 97(12):2978-87. PubMed ID: 12784332
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 31 patients and prognostic factors.
To EW; Lai EC; Cheng JH; Pang PC; Williams MD; Teo PM
Laryngoscope; 2002 Oct; 112(10):1877-82. PubMed ID: 12368634
[TBL] [Abstract][Full Text] [Related]
19. Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival.
Liao WT; Song LB; Zhang HZ; Zhang X; Zhang L; Liu WL; Feng Y; Guo BH; Mai HQ; Cao SM; Li MZ; Qin HD; Zeng YX; Zeng MS
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):508-14. PubMed ID: 17255272
[TBL] [Abstract][Full Text] [Related]
20. Effect of S-phase kinase-associated protein 2 expression on distant metastasis and survival in nasopharyngeal carcinoma patients.
Fang FM; Chien CY; Li CF; Shiu WY; Chen CH; Huang HY
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):202-7. PubMed ID: 18538504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
